Plantarc Bio Ltd. Logo

Plantarc Bio Ltd.

Develops gene discovery and RNAi technologies for crop enhancement and pest control.

PLNT | TA

Overview

Corporate Details

ISIN(s):
IL0011714040
LEI:
Country:
Israel
Address:
Birkat Am St 61-63, 4390500 Giv’at Hen

Description

Plantarc Bio Ltd. is an agricultural biotechnology company that develops solutions to enhance crop traits and address global food security. The company specializes in gene discovery and RNA interference (RNAi) technologies. It utilizes its proprietary Direct-In-Plant (DIP™) platform to discover genes that improve traits such as crop yield, drought resistance, herbicide tolerance, and insect resistance. The company also employs its DIPPER™ platform for gene-editing optimization. Additionally, Plantarc Bio develops RNAi-based products for biological pest control, targeting pests like the Red Palm Weevil, and for yield enhancement in crops including canola, soy, and rice.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-03-14 11:09
Presentation-World Agri-Tech Innovation Summit
English 9.4 MB
2023-03-14 11:09
Presentation-World Agri-Tech Innovation Summit
Russian 43.3 KB
2022-01-27 14:21
Plantarc – Appointment of a Market Maker, will not be included in the illiquid …
Hebrew (modern) 256.9 KB
2021-01-06 15:29
On Thursday, 7 January 2021, trading will commence in the following Security: P…
Hebrew (modern) 174.5 KB
2021-01-04 17:13
Identifying Details of New Security -PLANT ARC, PLANT ARC W1
Hebrew (modern) 178.5 KB
2020-11-18 16:16
Investor Presentation
English 1.8 MB
2020-11-18 16:16
Investor Presentation
Russian 42.7 KB

Automate Your Workflow. Get a real-time feed of all Plantarc Bio Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Plantarc Bio Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Plantarc Bio Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Pasithea Therapeutics Corp. Logo
Develops treatments for central nervous system disorders, RASopathies, and solid tumors.
United States of America
KTTA
Passage BIO, Inc. Logo
A clinical-stage genetic medicines company developing therapies for CNS disorders.
United States of America
PASG
PAVmed Inc. Logo
A diversified medical technology company developing devices, diagnostics, and digital health.
United States of America
PAVM
PepGen Inc. Logo
Develops oligonucleotide therapeutics for neuromuscular and neurological diseases.
United States of America
PEPG
Perseus Proteomics Inc. Logo
Develops antibody-based therapeutics, diagnostics, and research support services.
Japan
4882
PExA AB Logo
Develops non-invasive technology for respiratory medicine by analyzing exhaled air.
Sweden
PEXA B
Pharos iBio Co., Ltd. Logo
Clinical-stage biotech using AI to develop therapies for rare diseases and cancer.
South Korea
388870
Pherecydes Pharma Logo
A clinical-stage biotech company developing phage therapy for resistant infections.
France
ALPHE
PhoenixBio Co.,Ltd. Logo
A CRO providing humanized liver mouse models for preclinical drug studies.
Japan
6190
PILA PHARMA AB Logo
Clinical-stage biotech developing an oral TRPV1 antagonist for diabetes and obesity.
Sweden
PILA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.